These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 15003036)

  • 1. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of long-acting beta2-adrenoceptor agonism.
    Lipworth BJ
    Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.
    Barnes PJ
    Eur Respir J; 2002 Jan; 19(1):182-91. PubMed ID: 11843317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.
    Chung KF; Adcock IM
    Treat Respir Med; 2004; 3(5):279-89. PubMed ID: 15606218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
    Lipworth BJ
    Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta2-agonists or leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids for the treatment of persistent asthma.
    Ringdal N
    Drugs; 2003; 63 Suppl 2():21-33. PubMed ID: 14984078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
    Sin DD; Johnson M; Gan WQ; Man SF
    Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta2-agonists in asthma: not so SMART?
    Currie GP; Lee DK; Lipworth BJ
    Drug Saf; 2006; 29(8):647-56. PubMed ID: 16872239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
    Miller-Larsson A; Selroos O
    Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
    Lipworth BJ
    Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future.
    Anderson SD; Brannan JD
    Paediatr Drugs; 2004; 6(3):161-75. PubMed ID: 15170363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.